VIPR1 Antikörper (AA 305-334)
Kurzübersicht für VIPR1 Antikörper (AA 305-334) (ABIN1806297)
Target
Alle VIPR1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 305-334
-
Spezifität
- This VIPR1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 305-334 amino acids from the C-terminal region of human VIPR1.
-
Aufreinigung
- Protein A purified
-
-
-
-
Applikationshinweise
- Approved: WB (1:1000)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, 0.09 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.
-
Haltbarkeit
- 6 months
-
-
- VIPR1 (Vasoactive Intestinal Peptide Receptor 1 (VIPR1))
-
Andere Bezeichnung
- VIPR1 / RDC1
-
Hintergrund
-
Name/Gene ID: VIPR1
Subfamily: Vasoactive intestinal polypeptide
Family: GPCR
Synonyms: VIPR1, HVR1, PACAP type II receptor, PACAP-R-2, Pvr2, RDC1, Vip receptor subtype 1, Vpac1 receptor, V1RG, VIP receptor 1, VIPR, VIRG, VPCAP1R, PACAP-R2, VAPC1, VIP and PACAP receptor 1, VPAC1R, Pacap receptor, type ii, Type II PACAP receptor, VIP receptor, type I, VIP-R-1, VIP1 receptor, VPAC1 -
Gen-ID
- 7433
-
UniProt
- P32241
Target
-